Corebridge Financial Inc. Sells 5,754 Shares of Maximus, Inc. (NYSE:MMS)

Corebridge Financial Inc. cut its holdings in Maximus, Inc. (NYSE:MMS) by 5.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 97,579 shares of the health services provider’s stock after selling 5,754 shares during the quarter. Corebridge Financial Inc. owned about 0.17% of Maximus worth $7,284,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of MMS. Vanguard Group Inc. boosted its position in shares of Maximus by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock worth $488,829,000 after purchasing an additional 205,564 shares during the last quarter. Bridge City Capital LLC boosted its holdings in Maximus by 0.9% during the fourth quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider’s stock worth $2,128,000 after buying an additional 254 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Maximus during the 4th quarter worth about $1,821,000. AXQ Capital LP acquired a new position in shares of Maximus during the 4th quarter worth about $206,000. Finally, Hillsdale Investment Management Inc. increased its stake in shares of Maximus by 0.4% in the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider’s stock valued at $3,912,000 after acquiring an additional 230 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insider Transactions at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Maximus Trading Up 0.1 %

NYSE:MMS opened at $68.18 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The business’s 50-day simple moving average is $70.00 and its 200-day simple moving average is $77.89. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The stock has a market capitalization of $3.86 billion, a PE ratio of 14.66 and a beta of 0.71.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. The ex-dividend date of this dividend was Friday, February 14th. Maximus’s dividend payout ratio is 25.81%.

Analyst Ratings Changes

A number of brokerages recently issued reports on MMS. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.